Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$2.07

0.065 (3.25%)

07:38
11/04/19
11/04
07:38
11/04/19
07:38

BioCryst reports inducement grants under Nasdaq listing rule

BioCryst Pharmaceuticals announced that the compensation committee of BioCryst's board of directors granted five newly-hired employees options to purchase an aggregate of 217,500 shares of BioCryst common stock on October 31, 2019 as inducements material to each employee entering into employment with BioCryst. The options were granted in accordance with NASDAQ Listing Rule 5635(c)(4). The options have an exercise price of $2.00 per share, which is equal to the closing price of BioCryst common stock on the last business day prior to the grant date. The options vest in four equal annual installments beginning on the one-year anniversary of the grant date, in each case subject to the new employee's continued service with the company. Each stock option has a 10-year term and is subject to the terms and conditions of BioCryst's Inducement Equity Incentive Plan and a stock option agreement covering the grant.

  • 06

    Nov

BCRX BioCryst
$2.07

0.065 (3.25%)

05/23/19
JMPS
05/23/19
NO CHANGE
Target $10
JMPS
Outperform
BioCryst price target lowered to $10 from $18 at JMP Securities
JMP Securities analyst Liisa Bayko maintains an Outperform rating on BioCryst Pharmaceuticals after her talks with two key opinion leader doctors supported her view that HAE patients will want to try an oral option and BCX7353 could be "good enough" for a substantial proportion of them. However, she cut her price target on the shares to $10 from $18 to account for the fact that she lowered her U.S. launch price estimate to $250,000 from $500,000 annually.
05/24/19
RBCM
05/24/19
DOWNGRADE
Target $4.5
RBCM
Sector Perform
BioCryst downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Brian Abrahams downgraded BioCryst Pharmaceuticals to Sector Perform from Outperform and lowered his price target for the shares to $4.50 from $16.
05/24/19
05/24/19
DOWNGRADE
Target $4.5

Sector Perform
BioCryst downgraded to Sector Perform at RBC Capital on disappointing '7353 data
As previously reported, RBC Capital analyst Brian Abrahams downgraded BioCryst to Sector Perform from Outperform and lowered his price target to $4.50 from $16. The analyst cites the "disappointing" efficacy data for BCX7353, relegating the drug's potential to a "smaller niche role" even with discount pricing. Abrahams adds that although approvability risks for '7353 may be unfounded and the stock may bounce, he believes that the Street will have to turn more confident about its future revenues to offset the investments in filing and commercialization.
08/06/19
PIPR
08/06/19
NO CHANGE
Target $10
PIPR
Overweight
Piper Jaffray remains bullish on BioCryst, sees BCX7353 as viable product
Piper Jaffray analyst Tyler Van Buren reiterates an Overweight rating and $10 price target on BioCryst as he believes BCX7353 is a "viable product," while the rest of the pipeline is receiving little to no value. Having less than 12 months of cash is "clearly weighing" on the shares as the company heads toward a product launch in HAE prophylaxis, he acknowledges, but adds that he believes the company has several creative options at its disposal in addition to a potential strategic deal for ex-U.S. rights.

TODAY'S FREE FLY STORIES

AWK

American Water

$122.33

-0.15 (-0.12%)

08:25
12/11/19
12/11
08:25
12/11/19
08:25
Conference/Events
American Water to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 17

    Dec

HD

Home Depot

$215.84

-0.75 (-0.35%)

08:25
12/11/19
12/11
08:25
12/11/19
08:25
Conference/Events
Home Depot to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 25

    Feb

KWR

Quaker Houghton

$151.04

-1.7 (-1.11%)

08:25
12/11/19
12/11
08:25
12/11/19
08:25
Conference/Events
Quaker Houghton to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
12/11/19
12/11
08:24
12/11/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
12/11/19
12/11
08:24
12/11/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:24
12/11/19
12/11
08:24
12/11/19
08:24
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$191.21

-0.81 (-0.42%)

08:24
12/11/19
12/11
08:24
12/11/19
08:24
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$87.37

0.05 (0.06%)

08:23
12/11/19
12/11
08:23
12/11/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$59.78

0.15 (0.25%)

08:23
12/11/19
12/11
08:23
12/11/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$121.69

-0.19 (-0.16%)

08:23
12/11/19
12/11
08:23
12/11/19
08:23
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AM

Antero Midstream

$5.56

0.42 (8.18%)

, EPD

Enterprise Products

$27.19

0.48 (1.80%)

08:23
12/11/19
12/11
08:23
12/11/19
08:23
Conference/Events
Wells Fargo to hold a symposium »

18th Annual Midstream and…

AM

Antero Midstream

$5.56

0.42 (8.18%)

EPD

Enterprise Products

$27.19

0.48 (1.80%)

PSXP

Phillips 66 Partners

$56.04

0.335 (0.60%)

USAC

USA Compression

$15.89

-0.08 (-0.50%)

PAGP

Plains GP Holdings

$18.03

0.415 (2.36%)

KMI

Kinder Morgan

$20.12

0.175 (0.88%)

BIP

Brookfield Infrastructure

$51.73

-0.09 (-0.17%)

CCLP

CSI Compressco

$2.35

0.05 (2.17%)

ENLC

EnLink Midstream

$5.62

0.72 (14.69%)

WMB

Williams

$22.93

0.03 (0.13%)

TK

Teekay Corp.

$4.92

0.1 (2.07%)

TCP

TC PipeLines

$39.12

0.385 (0.99%)

BWP

Boardwalk Pipeline

$0.00

(0.00%)

HESM

Hess Midstream Partners

$20.98

0.31 (1.50%)

ENBL

Enable Midstream

$10.10

0.36 (3.70%)

MMP

Magellan Midstream

$60.57

0.49 (0.82%)

PPL

PPL Corp.

$33.80

0.11 (0.33%)

NS

NuStar Energy

$27.88

-0.27 (-0.96%)

GEL

Genesis Energy

$20.15

1.13 (5.94%)

OKE

Oneok

$72.49

0.28 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 07

    Jan

  • 10

    Feb

  • 26

    Feb

XLB

S&P Select Materials SPDR

$59.62

-0.37 (-0.62%)

08:23
12/11/19
12/11
08:23
12/11/19
08:23
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$62.98

-0.005 (-0.01%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$62.52

-0.24 (-0.38%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$304.54

2.52 (0.83%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Conference/Events
Cooper Companies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

XLV

Health Care Select Sector SPDR

$99.86

0.14 (0.14%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$162.58

0.11 (0.07%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDS

HD Supply

$39.07

-0.97 (-2.42%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Recommendations
HD Supply analyst commentary  »

HD Supply price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$279.48

-0.26 (-0.09%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$313.58

-0.29 (-0.09%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNQ

Canadian Natural

$29.51

0.4524 (1.56%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Upgrade
Canadian Natural rating change  »

Canadian Natural upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLF

Financial Select Sector

$30.28

(0.00%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$133.61

0.51 (0.38%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$203.90

-0.13 (-0.06%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.